“In Silico Evaluation of Natural Chalcones As Aromatase and EGFR Tyrosine Kinase Inhibitors to Combat Breast and Ovarian Cancers”. 2025. Vascular and Endovascular Review 8 (9s): 120-31. https://verjournal.com/index.php/ver/article/view/729.